Cargando…

Evolutionary analysis of FAM83H in vertebrates

Amelogenesis imperfecta is a group of disorders causing abnormalities in enamel formation in various phenotypes. Many mutations in the FAM83H gene have been identified to result in autosomal dominant hypocalcified amelogenesis imperfecta in different populations. However, the structure and function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Wushuang, Yang, Mei, Wang, Changning, Song, Yaling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500323/ https://www.ncbi.nlm.nih.gov/pubmed/28683132 http://dx.doi.org/10.1371/journal.pone.0180360

Ejemplares similares

The Enamel Phenotype in Homozygous Fam83h Truncation Mice
por: Wang, Shih‐Kai, et al.
Publicado: (2019)

Novel FAM83H mutations in patients with amelogenesis imperfecta
por: Xin, Wang, et al.
Publicado: (2017)

FAM83A and FAM83A-AS1 both play oncogenic roles in lung adenocarcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC
por: Richtmann, Sarah, et al.
Publicado: (2019)

FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas
por: Kim, Kyoung Min, et al.
Publicado: (2019)

LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation
por: Zhou, Min, et al.
Publicado: (2022)

Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of FAM83A and FAM83B
por: Cai, Ling, et al.
Publicado: (2019)

Long noncoding antisense RNA FAM83A‐AS1 promotes lung cancer cell progression by increasing FAM83A
por: Shi, Rongxing, et al.
Publicado: (2019)

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
por: Bartel, Courtney A., et al.
Publicado: (2017)

FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC
por: Kim, Kyoung Min, et al.
Publicado: (2017)

Casein kinase 1 is recruited to nuclear speckles by FAM83H and SON
por: Kuga, Takahisa, et al.
Publicado: (2016)

Missense Mutation in Fam83H Gene in Iranian Patients with Amelogenesis Imperfecta
por: POURHASHEMI, S Jalal, et al.
Publicado: (2014)

Immune implication of FAM83D gene in hepatocellular carcinoma
por: Meng, Tao, et al.
Publicado: (2021)

Fam83h null mice support a neomorphic mechanism for human ADHCAI
por: Wang, Shih‐Kai, et al.
Publicado: (2015)

LncRNA FAM83A‐AS1 promotes lung adenocarcinoma progression by enhancing the pre‐mRNA stability of FAM83A
por: Wang, Wenyi, et al.
Publicado: (2021)

Upregulation of FAM83D affects the proliferation and invasion of hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2015)

FAM83G Is a Novel Inducer of Apoptosis
por: Okada, Junichi, et al.
Publicado: (2020)

FAM83H and SCRIB stabilize β-catenin and stimulate progression of gastric carcinoma
por: Hussein, Usama Khamis, et al.
Publicado: (2020)

FAM83H‐AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma
por: Wang, Siwei, et al.
Publicado: (2021)

Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma
por: Ahn, Sung Woo, et al.
Publicado: (2020)

The clinical prognostic value of lncRNA FAM83H-AS1 in cancer patients: a meta-analysis
por: Yang, Qin, et al.
Publicado: (2020)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

A novel FAM83H variant causes familial amelogenesis imperfecta with incomplete penetrance
por: Bai, Rui‐Qi, et al.
Publicado: (2022)

Pan-cancer analysis of the FAM83 family and its association with prognosis and tumor microenvironment
por: Yuan, Shangkun, et al.
Publicado: (2022)

FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes
por: Kuga, Takahisa, et al.
Publicado: (2016)

Characterisation of the biochemical and cellular roles of native and pathogenic amelogenesis imperfecta mutants of FAM83H
por: Tachie-Menson, Theresa, et al.
Publicado: (2020)

Identification of a Novel FAM83H Mutation and Management of Hypocalcified Amelogenesis Imperfecta in Early Childhood
por: Song, Ji-Soo, et al.
Publicado: (2022)

FAM83A antisense RNA 1 (FAM83A-AS1) silencing impairs cell proliferation and induces autophagy via MET-AMPKɑ signaling in lung adenocarcinoma
por: Zhao, Huijie, et al.
Publicado: (2022)

FAM83A is a potential biomarker for breast cancer initiation
por: Marino, Natascia, et al.
Publicado: (2022)

CRISPR/Cas9‐mediated deletion of Fam83h induces defective tooth mineralization and hair development in rabbits
por: Zhang, Yuxin, et al.
Publicado: (2022)

FAM83H and Nectin1 expression are related with survival and relapse of bladder urothelial carcinoma patients
por: Ahn, Ae-Ri, et al.
Publicado: (2021)

A Recurrent FAM83H Mutation in an Extended Colombian Family and Variable Craniofacial Phenotypes
por: Alvarez, Camila, et al.
Publicado: (2022)

FAM83B is involved in thyroid cancer cell differentiation and migration
por: Cirello, Valentina, et al.
Publicado: (2022)

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
por: Yang, Fan, et al.
Publicado: (2016)

Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A
por: He, Jinyu, et al.
Publicado: (2019)

Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer
por: Jin, Yi, et al.
Publicado: (2022)

Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review
por: Jiang, Yi, et al.
Publicado: (2023)

Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer
por: Yuan, Xiaolei, et al.
Publicado: (2021)

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma
por: Zhang, Jing-Tao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a7scqdq2dpltnj5k0h3lvoek5u